Cargando…
Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients
SIMPLE SUMMARY: Osteosarcoma is a bone cancer with 75% of cases occurring in people younger than 25 years old. 35–45% of patients demonstrate resistance to chemotherapeutics and critically, survival rates for osteosarcoma is only 10–30% for patients with metastases. Therefore, reliable and patient-s...
Autores principales: | Brulin, Bénédicte, Nolan, John C., Marangon, Tecla, Kovacevic, Milan, Chatelais, Mathias, Meheust, Pierre, Abadie, Jérome, Le Nail, Louis-Romée, Rosset, Philippe, Brennan, Meadhbh Á., Layrolle, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507898/ https://www.ncbi.nlm.nih.gov/pubmed/34638373 http://dx.doi.org/10.3390/cancers13194890 |
Ejemplares similares
-
Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status
por: Avril, Pierre, et al.
Publicado: (2015) -
Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma
por: Le Nail, Louis-Romée, et al.
Publicado: (2018) -
Cold Plasma-Treated Ringer’s Saline: A Weapon to Target Osteosarcoma
por: Mateu-Sanz, Miguel, et al.
Publicado: (2020) -
Apoptotic mesenchymal stromal cells support osteoclastogenesis while inhibiting multinucleated giant cells formation in vitro
por: Humbert, Paul, et al.
Publicado: (2021) -
Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration
por: Humbert, Paul, et al.
Publicado: (2019)